TickerFacts.

Company research / PAHC

Phibro Animal Health Corp (PAHC)

Build a valuation ↗↓ Download CSV

SEC name PHIBRO ANIMAL HEALTH CORP · CIK 0001069899 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, Phibro Animal Health Corp reported revenue of $1.52B. Revenue grew 17.1% from the prior annual period.

Key ratios (year ended 2026-06-30)

33.8%
Gross margin
12.8%
Operating margin
6.6%
Net margin
25.9%
Return on year-end equity
17.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form DEF 14A (proxy statement) · 2026-09-18

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$1.52B$1.30B$1.02B$977.89M$942.26M$833.35M$800.35M$828.00M$819.98M$764.28M
Cost of Revenue$1.01B$896.27M$704.59M$679.65M$656.86M$561.97M$543.47M$563.37M$553.10M$516.04M
Gross Profit$512.51M$399.94M$313.09M$298.24M$285.40M$271.38M$256.88M$264.62M$266.88M$248.24M
R&D Expense$24.55M$23.73M$29.19M$24.39M$20.83M$17.76M$13.74M$12.09M$10.00M$9.44M
Operating Income$194.40M$110.47M$53.31M$71.85M$78.99M$74.87M$69.19M$83.23M$98.93M$97.93M
Depreciation & Amortization$51.51M$45.60M$36.18M$34.01M$32.70M$31.89M$32.34M$27.56M$26.94M$26.00M
EBITDA$245.91M$156.07M$89.49M$105.86M$111.69M$106.75M$101.53M$110.79M$125.87M$123.94M
Net Income$99.72M$48.26M$2.42M$32.61M$49.17M$54.38M$33.55M$54.71M$64.88M$64.61M
EPS (Diluted)$2.43$1.19$0.06$0.81$1.21$1.34$0.83$1.35$1.61$1.61
Total Assets$1.50B$1.36B$982.18M$971.40M$931.70M$841.33M$784.10M$726.67M$671.68M$623.40M
Total Liabilities$1.12B$1.08B$725.54M$688.89M$669.26M$602.80M$595.90M$510.66M$486.73M$472.24M
Long-Term Debtn/an/a$312.08M$333.84M$287.93Mn/an/an/an/an/a
Shareholders' Equity$385.48M$285.68M$256.64M$282.51M$262.44M$238.53M$188.20M$216.01M$184.95M$151.16M
Cash & Equivalents$61.42M$68.04M$70.61M$41.28M$74.25M$50.21M$36.34M$57.57M$29.17M$56.08M
Operating Cash Flow$68.95M$80.12M$87.59M$13.31M$31.65M$48.31M$59.35M$47.17M$70.01M$98.39M
Capital Expenditures$59.09M$38.29M$41.24M$51.79M$37.04M$29.32M$34.05M$29.89M$18.55M$20.88M
Free Cash Flow$9.87M$41.83M$46.36M-$38.48M-$5.39M$18.99M$25.30M$17.28M$51.46M$77.50M
Dividends Paid$19.46M$19.45M$19.44M$19.44M$19.44M$19.43M$19.42M$18.59M$16.07M$15.83M
Dividends Per Share$0.48$0.48$0.48$0.48$0.48$0.48$0.48$0.46$0.40$0.40
Weighted Average Diluted Shares40.96M40.68M40.52M40.50M40.50M40.50M40.50Mn/an/a40.04M
EPS (Basic)$2.46$1.19$0.06$0.81$1.21$1.34$0.83$1.35$1.61$1.63

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView